French pharmaceutical giant Sanofi has agreed to help Moderna manufacture some 200 million doses of its Covid-19 vaccine in the U.S., the company announced Monday, removing a key bottleneck in Moderna’s supply chain that will boost U.S. supplies well into 2022.
